Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lassmann

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 20, 2015
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human StudiesMartina Weineisen, Margret Schottelius, Jakub Simecek, et al.
Theranostics|July 27, 2017
[<sup>177</sup>Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic AgentMargret Schottelius, Theresa Osl, Andreas Poschenrieder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 21, 2015
Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixaforKen Herrmann, Constantin Lapa, Hans-Juergen Wester, et al.
Physics in Medicine and Biology|February 11, 2015
Differences in 3D dose distributions due to calculation method of voxel S-values and the influence of image blurring in SPECTMassimiliano Pacilio, Ernesto Amato, Nico Lanconelli, et al.
Theranostics|April 1, 2015
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imagingHans Jürgen Wester, Ulrich Keller, Margret Schottelius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2023
Renal and Multiorgan Safety of <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry SubstudyKen Herrmann, Kambiz Rahbar, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2023
Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage CardJohannes Tran-Gia, Uta Eberlein, Michael Lassmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2014
Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin MicrospheresCarlo Chiesa, Bieke Lambert, Marco Maccauro, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2016
Synthesis and preclinical evaluation of an Al<sup>18</sup>F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligandStefano Boschi, Jason T Lee, Seval Beykan, et al.
Nuclear Medicine and Biology|May 11, 2018
Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<sub>3</sub>-TATE: A potential PET tracer for clinical imaging of somatostatin receptorsKsenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 20, 2015
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human StudiesMartina Weineisen, Margret Schottelius, Jakub Simecek, et al.
Theranostics|July 27, 2017
[<sup>177</sup>Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic AgentMargret Schottelius, Theresa Osl, Andreas Poschenrieder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 21, 2015
Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixaforKen Herrmann, Constantin Lapa, Hans-Juergen Wester, et al.
Physics in Medicine and Biology|February 11, 2015
Differences in 3D dose distributions due to calculation method of voxel S-values and the influence of image blurring in SPECTMassimiliano Pacilio, Ernesto Amato, Nico Lanconelli, et al.
Theranostics|April 1, 2015
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imagingHans Jürgen Wester, Ulrich Keller, Margret Schottelius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2023
Renal and Multiorgan Safety of <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry SubstudyKen Herrmann, Kambiz Rahbar, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2023
Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage CardJohannes Tran-Gia, Uta Eberlein, Michael Lassmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2014
Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin MicrospheresCarlo Chiesa, Bieke Lambert, Marco Maccauro, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2016
Synthesis and preclinical evaluation of an Al<sup>18</sup>F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligandStefano Boschi, Jason T Lee, Seval Beykan, et al.
Nuclear Medicine and Biology|May 11, 2018
Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<sub>3</sub>-TATE: A potential PET tracer for clinical imaging of somatostatin receptorsKsenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, et al.
Pageof 17